Plain-English translation of NCT06027892 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our PROSTATE CANCER research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether men with early-stage prostate cancer can be treated effectively with just two doses of focused radiation therapy, rather than the standard five doses. The goal is to see if the shorter schedule works just as well while making treatment more convenient and efficient for patients.
Prostate cancer is very common, and many treatment centers see high volumes of patients. This trial exists because doctors want to find the fastest, most efficient way to treat early prostate cancer that still gives excellent results—potentially saving patients time and medical resources.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either two focused radiation treatments or five treatments over a longer period. The radiation is delivered by a machine and is non-invasive—you will not need surgery or anesthesia. Your doctors will monitor you over time to see how well the treatment works and track any side effects.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
Israel